IBDEI0HM ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,7933,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7933,1,3,0)
;;=3^Pruritus Ani
;;^UTILITY(U,$J,358.3,7933,1,4,0)
;;=4^L29.0
;;^UTILITY(U,$J,358.3,7933,2)
;;=^100061
;;^UTILITY(U,$J,358.3,7934,0)
;;=L29.9^^39^391^291
;;^UTILITY(U,$J,358.3,7934,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7934,1,3,0)
;;=3^Pruritus,Unspec
;;^UTILITY(U,$J,358.3,7934,1,4,0)
;;=4^L29.9
;;^UTILITY(U,$J,358.3,7934,2)
;;=^5009153
;;^UTILITY(U,$J,358.3,7935,0)
;;=L30.0^^39^391^270
;;^UTILITY(U,$J,358.3,7935,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7935,1,3,0)
;;=3^Nummular Dermatitis
;;^UTILITY(U,$J,358.3,7935,1,4,0)
;;=4^L30.0
;;^UTILITY(U,$J,358.3,7935,2)
;;=^186823
;;^UTILITY(U,$J,358.3,7936,0)
;;=L30.1^^39^391^143
;;^UTILITY(U,$J,358.3,7936,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7936,1,3,0)
;;=3^Dyshidrosis
;;^UTILITY(U,$J,358.3,7936,1,4,0)
;;=4^L30.1
;;^UTILITY(U,$J,358.3,7936,2)
;;=^5009154
;;^UTILITY(U,$J,358.3,7937,0)
;;=L30.2^^39^391^135
;;^UTILITY(U,$J,358.3,7937,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7937,1,3,0)
;;=3^Cutaneous Autosensitization
;;^UTILITY(U,$J,358.3,7937,1,4,0)
;;=4^L30.2
;;^UTILITY(U,$J,358.3,7937,2)
;;=^5009155
;;^UTILITY(U,$J,358.3,7938,0)
;;=L30.4^^39^391^147
;;^UTILITY(U,$J,358.3,7938,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7938,1,3,0)
;;=3^Erythema Intertrigo
;;^UTILITY(U,$J,358.3,7938,1,4,0)
;;=4^L30.4
;;^UTILITY(U,$J,358.3,7938,2)
;;=^5009157
;;^UTILITY(U,$J,358.3,7939,0)
;;=L30.8^^39^391^138
;;^UTILITY(U,$J,358.3,7939,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7939,1,3,0)
;;=3^Dermatitis NEC
;;^UTILITY(U,$J,358.3,7939,1,4,0)
;;=4^L30.8
;;^UTILITY(U,$J,358.3,7939,2)
;;=^5009158
;;^UTILITY(U,$J,358.3,7940,0)
;;=L30.9^^39^391^139
;;^UTILITY(U,$J,358.3,7940,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7940,1,3,0)
;;=3^Dermatitis,Unspec
;;^UTILITY(U,$J,358.3,7940,1,4,0)
;;=4^L30.9
;;^UTILITY(U,$J,358.3,7940,2)
;;=^5009159
;;^UTILITY(U,$J,358.3,7941,0)
;;=L40.0^^39^391^293
;;^UTILITY(U,$J,358.3,7941,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7941,1,3,0)
;;=3^Psoriasis Vulgaris
;;^UTILITY(U,$J,358.3,7941,1,4,0)
;;=4^L40.0
;;^UTILITY(U,$J,358.3,7941,2)
;;=^5009160
;;^UTILITY(U,$J,358.3,7942,0)
;;=L40.1^^39^391^296
;;^UTILITY(U,$J,358.3,7942,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7942,1,3,0)
;;=3^Pustulosis Psoriasis,Generalized
;;^UTILITY(U,$J,358.3,7942,1,4,0)
;;=4^L40.1
;;^UTILITY(U,$J,358.3,7942,2)
;;=^5009161
;;^UTILITY(U,$J,358.3,7943,0)
;;=L40.2^^39^391^12
;;^UTILITY(U,$J,358.3,7943,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7943,1,3,0)
;;=3^Acrodermatitis Continua
;;^UTILITY(U,$J,358.3,7943,1,4,0)
;;=4^L40.2
;;^UTILITY(U,$J,358.3,7943,2)
;;=^5009162
;;^UTILITY(U,$J,358.3,7944,0)
;;=L40.3^^39^391^295
;;^UTILITY(U,$J,358.3,7944,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7944,1,3,0)
;;=3^Pustulosis Palmaris et Plantaris
;;^UTILITY(U,$J,358.3,7944,1,4,0)
;;=4^L40.3
;;^UTILITY(U,$J,358.3,7944,2)
;;=^5009163
;;^UTILITY(U,$J,358.3,7945,0)
;;=L40.4^^39^391^160
;;^UTILITY(U,$J,358.3,7945,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7945,1,3,0)
;;=3^Guttate Psoriasis
;;^UTILITY(U,$J,358.3,7945,1,4,0)
;;=4^L40.4
;;^UTILITY(U,$J,358.3,7945,2)
;;=^5009164
;;^UTILITY(U,$J,358.3,7946,0)
;;=L40.8^^39^391^292
;;^UTILITY(U,$J,358.3,7946,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0HM 3773 printed Sep 23, 2025@19:24:50 Page 2
IBDEI0HM ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,7933,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,7933,1,3,0)
+4 ;;=3^Pruritus Ani
+5 ;;^UTILITY(U,$J,358.3,7933,1,4,0)
+6 ;;=4^L29.0
+7 ;;^UTILITY(U,$J,358.3,7933,2)
+8 ;;=^100061
+9 ;;^UTILITY(U,$J,358.3,7934,0)
+10 ;;=L29.9^^39^391^291
+11 ;;^UTILITY(U,$J,358.3,7934,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,7934,1,3,0)
+14 ;;=3^Pruritus,Unspec
+15 ;;^UTILITY(U,$J,358.3,7934,1,4,0)
+16 ;;=4^L29.9
+17 ;;^UTILITY(U,$J,358.3,7934,2)
+18 ;;=^5009153
+19 ;;^UTILITY(U,$J,358.3,7935,0)
+20 ;;=L30.0^^39^391^270
+21 ;;^UTILITY(U,$J,358.3,7935,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,7935,1,3,0)
+24 ;;=3^Nummular Dermatitis
+25 ;;^UTILITY(U,$J,358.3,7935,1,4,0)
+26 ;;=4^L30.0
+27 ;;^UTILITY(U,$J,358.3,7935,2)
+28 ;;=^186823
+29 ;;^UTILITY(U,$J,358.3,7936,0)
+30 ;;=L30.1^^39^391^143
+31 ;;^UTILITY(U,$J,358.3,7936,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,7936,1,3,0)
+34 ;;=3^Dyshidrosis
+35 ;;^UTILITY(U,$J,358.3,7936,1,4,0)
+36 ;;=4^L30.1
+37 ;;^UTILITY(U,$J,358.3,7936,2)
+38 ;;=^5009154
+39 ;;^UTILITY(U,$J,358.3,7937,0)
+40 ;;=L30.2^^39^391^135
+41 ;;^UTILITY(U,$J,358.3,7937,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,7937,1,3,0)
+44 ;;=3^Cutaneous Autosensitization
+45 ;;^UTILITY(U,$J,358.3,7937,1,4,0)
+46 ;;=4^L30.2
+47 ;;^UTILITY(U,$J,358.3,7937,2)
+48 ;;=^5009155
+49 ;;^UTILITY(U,$J,358.3,7938,0)
+50 ;;=L30.4^^39^391^147
+51 ;;^UTILITY(U,$J,358.3,7938,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,7938,1,3,0)
+54 ;;=3^Erythema Intertrigo
+55 ;;^UTILITY(U,$J,358.3,7938,1,4,0)
+56 ;;=4^L30.4
+57 ;;^UTILITY(U,$J,358.3,7938,2)
+58 ;;=^5009157
+59 ;;^UTILITY(U,$J,358.3,7939,0)
+60 ;;=L30.8^^39^391^138
+61 ;;^UTILITY(U,$J,358.3,7939,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,7939,1,3,0)
+64 ;;=3^Dermatitis NEC
+65 ;;^UTILITY(U,$J,358.3,7939,1,4,0)
+66 ;;=4^L30.8
+67 ;;^UTILITY(U,$J,358.3,7939,2)
+68 ;;=^5009158
+69 ;;^UTILITY(U,$J,358.3,7940,0)
+70 ;;=L30.9^^39^391^139
+71 ;;^UTILITY(U,$J,358.3,7940,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,7940,1,3,0)
+74 ;;=3^Dermatitis,Unspec
+75 ;;^UTILITY(U,$J,358.3,7940,1,4,0)
+76 ;;=4^L30.9
+77 ;;^UTILITY(U,$J,358.3,7940,2)
+78 ;;=^5009159
+79 ;;^UTILITY(U,$J,358.3,7941,0)
+80 ;;=L40.0^^39^391^293
+81 ;;^UTILITY(U,$J,358.3,7941,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,7941,1,3,0)
+84 ;;=3^Psoriasis Vulgaris
+85 ;;^UTILITY(U,$J,358.3,7941,1,4,0)
+86 ;;=4^L40.0
+87 ;;^UTILITY(U,$J,358.3,7941,2)
+88 ;;=^5009160
+89 ;;^UTILITY(U,$J,358.3,7942,0)
+90 ;;=L40.1^^39^391^296
+91 ;;^UTILITY(U,$J,358.3,7942,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,7942,1,3,0)
+94 ;;=3^Pustulosis Psoriasis,Generalized
+95 ;;^UTILITY(U,$J,358.3,7942,1,4,0)
+96 ;;=4^L40.1
+97 ;;^UTILITY(U,$J,358.3,7942,2)
+98 ;;=^5009161
+99 ;;^UTILITY(U,$J,358.3,7943,0)
+100 ;;=L40.2^^39^391^12
+101 ;;^UTILITY(U,$J,358.3,7943,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,7943,1,3,0)
+104 ;;=3^Acrodermatitis Continua
+105 ;;^UTILITY(U,$J,358.3,7943,1,4,0)
+106 ;;=4^L40.2
+107 ;;^UTILITY(U,$J,358.3,7943,2)
+108 ;;=^5009162
+109 ;;^UTILITY(U,$J,358.3,7944,0)
+110 ;;=L40.3^^39^391^295
+111 ;;^UTILITY(U,$J,358.3,7944,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,7944,1,3,0)
+114 ;;=3^Pustulosis Palmaris et Plantaris
+115 ;;^UTILITY(U,$J,358.3,7944,1,4,0)
+116 ;;=4^L40.3
+117 ;;^UTILITY(U,$J,358.3,7944,2)
+118 ;;=^5009163
+119 ;;^UTILITY(U,$J,358.3,7945,0)
+120 ;;=L40.4^^39^391^160
+121 ;;^UTILITY(U,$J,358.3,7945,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,7945,1,3,0)
+124 ;;=3^Guttate Psoriasis
+125 ;;^UTILITY(U,$J,358.3,7945,1,4,0)
+126 ;;=4^L40.4
+127 ;;^UTILITY(U,$J,358.3,7945,2)
+128 ;;=^5009164
+129 ;;^UTILITY(U,$J,358.3,7946,0)
+130 ;;=L40.8^^39^391^292
+131 ;;^UTILITY(U,$J,358.3,7946,1,0)
+132 ;;=^358.31IA^4^2
